All In MedTech

Device Trial Radar · NCT03626623

Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care

A Prospective, Randomized, Controlled Trial Comparing Cytal Wound Matrix 1-Layer to Standard of Care (SOC) in the Management of Diabetic Foot Ulcers (DFUs)

Last checked: Nov 20, 2026Latest source record: Aug 25, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

15

Actual

Start

May 21, 2019

Primary completion

Feb 18, 2020

Study completion Feb 18, 2020

Sponsor

Lead sponsor
Integra LifeSciences CorporationPublic (IART)
Sponsor type
Industry
First posted
Aug 13, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a two-armed randomized controlled trial (RCT) primarily aimed at determining if application of Cytal Wound Matrix 1-Layer intervention to diabetic foot ulcers shows improved wound closure rates when compared to standard care intervention.

Conditions

  • Diabetes
  • Diabetic Foot
  • Diabetes Mellitus, Type 2
  • Diabetes Mellitus, Type 1

Interventions

  • Cytal Wound Matrix 1-LayerDevice

    Cytal® Wound Matrix 1-Layer is composed of a porcine (pig) derived extracellular matrix known as urinary bladder matrix. It is intended for the management of a variety of wounds.The individual device is intended for one time use.

  • Standard of Care (SOC)Other

    Standard of care (SOC) is defined as the usual care a licensed health care provider would give patients to treat diabetic foot ulcers or wounds. SOC associated procedures and policies may vary across clinical settings.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Wounds With Wound ClosureTime frame: up to 12 weeks

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Limb Preservation Platform, Inc.

    Fresno, California

  • Louisiana State University Health Science Center (LSUHSC)

    New Orleans, Louisiana

  • MedStar Health Research Institute

    Hyattsville, Maryland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.